Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R. N. Damle"'
Publikováno v:
International Journal of Cancer. 50:192-196
Soluble inhibitory factors (SIF) have been demonstrated in the sera of cancer patients, which interfere with the T-cell activation process. We have shown that the major contributory factor to the inhibitory effect of sera from patients with Hodgkin's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd8666a7041a7378a4c81105983f2cb
https://doi.org/10.1002/ijc.2910500206
https://doi.org/10.1002/ijc.2910500206
Autor:
Revati J. Tatake, Nirmala Rajaram, R. N. Damle, Gangal Sg, Binaifer R. Balsara, Avinash N. Bhisey
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 116:179-186
Four cell lines were established from squamous cell carcinomas (SCC) of the oral cavity. Cell lines AW 13516 and AW 8507 were derived from poorly differentiated SCC and epidermoid carcinoma of the tongue respectively. Cell line AW 10498 was derived f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c15c1562752e592c0eb478c6ad089a
https://doi.org/10.1007/bf01612674
https://doi.org/10.1007/bf01612674
Publikováno v:
Indian journal of biochemistrybiophysics. 31(4)
T cell dysfunction in Hodgkin's disease (HD) is well documented. Since interleukin-2 (IL-2) plays a pivotal role in T cell proliferation, we have investigated frequency distribution of IL-2 producing phytohaemagglutinin (PHA)-stimulated lymphocytes f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a235a555b8c93072c5ab4fc955bdb539
https://pubmed.ncbi.nlm.nih.gov/8002002
https://pubmed.ncbi.nlm.nih.gov/8002002
Publikováno v:
The Indian journal of medical research. 96
T cell activation process in patients of Hodgkin's disease was studied in terms of cellular protein phosphorylation following interaction of T lymphocytes with mitogen PHA. Peripheral blood lymphocytes from Hodgkin's disease patients and healthy dono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::489cb3b5fa0f88b74ee27ca04269b1a8
https://pubmed.ncbi.nlm.nih.gov/1428061
https://pubmed.ncbi.nlm.nih.gov/1428061
Autor:
X. Yan, Kanti R. Rai, Nina Kohn, C. Johnson, N. Driscoll, Yehuda Lebowicz, Matthew Kaufman, N. Chiorazzi, R. N. Damle
Publikováno v:
Journal of Clinical Oncology. 26:7068-7068
7068 Background: IgVH mutation status is a well accepted prognostic marker in chronic lymphocytic leukemia (CLL). Typically >98% of the germline sequence homology is considered unmutated, and =98% ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66cc857f15ff3637d25935cf9620377a
https://doi.org/10.1200/jco.2008.26.15_suppl.7068
https://doi.org/10.1200/jco.2008.26.15_suppl.7068
Autor:
Steven L. Allen, Emilia Albesiano, T. Wasil, N. Chiorazzi, Kanti R. Rai, Jonathan E. Kolitz, R. N. Damle
Publikováno v:
Journal of Clinical Oncology. 23:6555-6555
6555 Background: Clinical outcome in B-CLL is correlated IgVH gene mutations and CD38 expresion A recent study repoted that expression of ZAP-70 and IgVH gene mutations could be correlated with tim...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11a8be923a1a3e4dbe4c37aacd089eb8
https://doi.org/10.1200/jco.2005.23.16_suppl.6555
https://doi.org/10.1200/jco.2005.23.16_suppl.6555
Publikováno v:
Journal of Investigative Medicine. 52:S389.5-S389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a69b30b730c06bc27b3b28160a579bf
https://doi.org/10.1136/jim-52-suppl2-147
https://doi.org/10.1136/jim-52-suppl2-147
Publikováno v:
Journal of Investigative Medicine. 52:389-389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e2a8288c1baa2e80797e27e1ecfd485
https://doi.org/10.1177/108155890405202s147
https://doi.org/10.1177/108155890405202s147